Thus, cardiomyocyte-specific OPA1 knockdown significantly attenuated the beneficial impact of PFKFB3 on cardiac structure and function, underscoring the PFKFB3’s protective effect against DCM depending on the presence of OPA1. Here, OPA1 is linked to familial dilated cardiomyopathy.